Loading company details...
Latest Form 4 (Sep 17, 2026): Michael Thomas Heffernan (Director): Exercise/Conversion of 18,421 shares, $56.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Michael Thomas Heffernan | Exercise/Conversion | 18,421 | $56.0K |
| Jun 4, 2026 | Edward T. Mathers | Grant/Award | 35,000 | n/a |
| Jun 4, 2026 | Dominick Colangelo | Grant/Award | 35,000 | n/a |
| Jun 4, 2026 | David P. Meeker | Grant/Award | 35,000 | n/a |
| Jun 4, 2026 | Anne Vanlent | Grant/Award | 35,000 | n/a |
| Jun 4, 2026 | Michael Thomas Heffernan | Grant/Award | 35,000 | n/a |
| Feb 20, 2026 | James Cassella V, Chief Development Officer | Grant/Award | 215,000 | n/a |
| Feb 20, 2026 | Christopher Galletta, Controller and Principal Accounting Officer | Grant/Award | 35,000 | n/a |
| Feb 20, 2026 | Thomas Sciascia, Chief Scientific Officer | Grant/Award | 85,000 | n/a |
| Feb 20, 2026 | Jennifer L. Good, President & CEO | Grant/Award | 675,000 | n/a |